New clearance expands insulin management capabilities to include Bolus and Premixed Insulin titration COLUMBIA, MD, Sept. 22, 2021 — Welldoc, a digital health leader revolutionizing chronic care, today announced the receipt of its ninth 510(k) clearance from the Food and Drug Administration (FDA) for its award-winning diabetes platform, BlueStar®. The new clearance expands insulin dosing … Continue reading Welldoc Receives Ninth 510(k) for Award-Winning Diabetes Platform, BlueStar®